IEFQ:LSE:LSE-iShares Edge MSCIope Quality Factor UCITS (GBX)

ETF | Others |

Last Closing

USD 838.8

Change

+2.25 (+0.27)%

Market Cap

N/A

Volume

6.79K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-24 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

-0.50 (-0.22%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+3.06 (+2.24%)

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.12 (+0.67%)

USD 562.96B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.06 (+0.46%)

USD 562.96B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

+0.30 (+0.48%)

USD 266.08B
0QZO:LSE 0QZO

+0.30 (+0.27%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

+0.22 (+0.75%)

USD 211.57B
0QZ3:LSE Qualcomm Inc.

-0.21 (-0.13%)

USD 202.26B
0R24:LSE Intel Corp.

+0.24 (+1.20%)

USD 196.14B

ETFs Containing IEFQ:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.05% 24% F 38% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.05% 20% F 35% F
Trailing 12 Months  
Capital Gain -0.27% 25% F 39% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.27% 21% F 36% F
Trailing 5 Years  
Capital Gain 30.07% 58% F 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 30.07% 55% F 65% D
Average Annual (5 Year Horizon)  
Capital Gain 9.61% 61% D- 65% D
Dividend Return 9.61% 60% D- 65% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.64% 65% D 80% B-
Risk Adjusted Return 90.36% 86% B+ 92% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike